Literature DB >> 35444731

Expectant management of a parturient with serotonin syndrome: A case report.

Brandon Hammond1, Lacey Straube1, Benjamin Cobb1.   

Abstract

Serotonin syndrome is a potentially fatal condition caused by central nervous system serotonergic overactivity. The primary principle of managing serotonin syndrome in pregnancy focuses on discontinuation of offending agents and supportive care. In general, delivery should be avoided pending resolution of serotonin syndrome.
© The Author(s) 2020.

Entities:  

Keywords:  Obstetric anesthesia; psychiatric parturient management; serotonin syndrome

Year:  2020        PMID： 35444731      PMCID： PMC9014551          DOI： 10.1177/1753495X20971155

Source DB:  PubMed          Journal:  Obstet Med        ISSN： 1753-495X


  8 in total

1.  The Hunter Serotonin Toxicity Criteria: simple and accurate diagnostic decision rules for serotonin toxicity.

Authors:  E J C Dunkley; G K Isbister; D Sibbritt; A H Dawson; I M Whyte
Journal:  QJM       Date:  2003-09

Review 2.  The serotonin syndrome.

Authors:  Edward W Boyer; Michael Shannon
Journal:  N Engl J Med       Date:  2005-03-17       Impact factor: 91.245

3.  ACOG Practice Bulletin No. 87 November 2007: Use of psychiatric medications during pregnancy and lactation.

Authors: 
Journal:  Obstet Gynecol       Date:  2007-11       Impact factor: 7.661

Review 4.  Practice bulletin no. 145: antepartum fetal surveillance.

Authors: 
Journal:  Obstet Gynecol       Date:  2014-07       Impact factor: 7.661

5.  ACOG Committee Opinion No. 354: Treatment with selective serotonin reuptake inhibitors during pregnancy.

Authors: 
Journal:  Obstet Gynecol       Date:  2006-12       Impact factor: 7.661

Review 6.  Starvation ketoacidosis in pregnancy.

Authors:  Charlotte J Frise; Lucy Mackillop; Karen Joash; Catherine Williamson
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2012-11-04       Impact factor: 2.435

7.  Antipsychotic-induced insulin resistance and postprandial hormonal dysregulation independent of weight gain or psychiatric disease.

Authors:  Karen L Teff; Michael R Rickels; Joanna Grudziak; Carissa Fuller; Huong-Lan Nguyen; Karl Rickels
Journal:  Diabetes       Date:  2013-07-08       Impact factor: 9.461
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.